Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Subject

Automation (7)
Biotechnology (1)
Business aspects (13)
Construction Technology (8)
Coordination and Cooperation (7)
Economic Aspects (6)
Education and Training (7)
Electronics and Microelectronics (1)
Food (1)
Funding Programmes (1)
Healthcare delivery/services (16)
Industrial biotech (7)
Information Processing and Information Systems (6)
Information and Media (7)
Information and communication technology applications (6)
Innovation and Technology Transfer (17)
Life Sciences (2)
Materials Technology (9)
Measurement Methods (6)
Medical biotechnology (19)
Medicine and Health (21)
Nanotechnology and Nanosciences (26)
Other (1)
Policies (7)
Regional Development (1)
Resources of the Sea and Fisheries (1)
Safety (7)
Scientific Research (14)
Standards (7)
Water resources and management (1)

Country

Austria (21)
Belgium (34)
Bulgaria (4)
Canada (2)
Chile (1)
China (1)
Cyprus (3)
Czech Republic (3)
Denmark (21)
Estonia (5)
Finland (20)
France (55)
Germany (74)
Greece (15)
Hungary (7)
Ireland (16)
Israel (22)
Italy (107)
Latvia (4)
Lithuania (6)
Luxembourg (4)
Malta (9)
Netherlands (43)
Norway (15)
Poland (11)
Portugal (26)
Romania (4)
Russia (2)
Slovakia (6)
Slovenia (9)
South Africa (1)
South Korea (1)
Spain (104)
Sweden (26)
Switzerland (15)
Taiwan (1)
Tunisia (1)
Turkey (4)
Ukraine (1)
United Kingdom (83)
United States (1)

Content Type

Project (299)
News (31)
Event (13)
Report Summary (153)
Programme (107)

Language

Deutsch (11)
English (522)
Español (11)
Français (11)
Italiano (11)
Polski (11)

Advanced search

Results 1 - 10 of 603
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Manufacturing the future of nanomedicine
EU-funded RNA-based therapy targets the direct cause of some neurodegenerative diseases, not just their symptoms.
Programme: H2020-EU.2.1.2.
Record Number: 128346
Last updated on: 2017-05-31
Available languages: DE, EN, ES, FR, IT, PL
Die Zukunft der Nanomedizin wird hervorgebracht
Eine EU-finanzierte Therapie auf RNA-Basis zielt auf die direkte Ursache einiger neurodegenerativer Erkrankungen ab und nicht nur auf ihre Symptome.
Programme: H2020-EU.2.1.2.
Record Number: 128346
Last updated on: 2017-05-31
Available languages: DE, EN, ES, FR, IT, PL
Fabricar el futuro de la nanomedicina
Una terapia de ARN obtenida gracias a fondos europeos actúa sobre la principal causa de algunas enfermedades neurodegenerativas y no solo sobre sus síntomas.
Programme: H2020-EU.2.1.2.
Record Number: 128346
Last updated on: 2017-05-31
Available languages: DE, EN, ES, FR, IT, PL
Fabbricare il futuro della nanomedicina
Una terapia basata sugli RNA, finanziata dall’UE, affronta la causa diretta di alcune malattie neurodegenerative e non soltanto i loro sintomi.
Programme: H2020-EU.2.1.2.
Record Number: 128346
Last updated on: 2017-05-31
Available languages: DE, EN, ES, FR, IT, PL
Fabriquer l'avenir de la nanomédecine
La thérapie à base d'ARN financée par l'UE cible la cause directe de certaines maladies neurodégénératives, sans se limiter à leurs symptômes.
Programme: H2020-EU.2.1.2.
Record Number: 128346
Last updated on: 2017-05-31
Available languages: DE, EN, ES, FR, IT, PL
Wytwarzanie nanoleków jutra
Finansowana ze środków UE terapia na bazie RNA obiera za cel przyczyny chorób neurodegeneracyjnych, a nie tylko ich objawy.
Programme: H2020-EU.2.1.2.
Record Number: 128346
Last updated on: 2017-05-31
Available languages: DE, EN, ES, FR, IT, PL
New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinase 3
ID: 720905
Start date: 2017-01-01, End date: 2020-12-31
Inflammatory bowel diseases (IBD) are the second most common immune-mediated disorders in Europe, affecting more particularly young people. The current therapies, including antibodies, show three main drawbacks: efficacy, tolerability and convenience. NEW DEAL solution will...
Programme: H2020-EU.2.1.2.
Record Number: 206567
Last updated on: 2017-02-22
Nanomedicine Translation around the globe - How to proper address regulatory processes for nanomedicines in different countries.
ENATRANS, the pathfinder for Nanobiomedical Translation, extends its compendium for nanomedicine entrepreneurs, SMEs and researchers with synopses of regulation processes in countries of major interest. Therefore packages with basic information on regulatory processes for USA, China, Japan, India, Brazil and South Korea are currently available on ENATRANS website.
Programme: H2020-EU.2.1.2.
Record Number: 141416
Last updated on: 2017-06-20
TAPEMELT: Recyclable thermal activated tape system
ID: 762568
Start date: 2017-02-01, End date: 2017-05-31
Packaging tapes are the most widely used pressure sensitive adhesive tapes with global production in excess of 10 billion sq. meters per year . Their primary application is corrugated carton closure. However, existing solutions for this application present 3 key...
Programme: H2020-EU.2.1.5.
Record Number: 208160
Last updated on: 2017-05-23
InCa - Cardio Watch for Continuous Intra-Cardiac Blood Pressure Sensing
ID: 745538
Start date: 2016-12-01, End date: 2017-04-30
Congestive Heart failure (CHF) affects more than 15 million European citizens and 1 in 5 people are at risk of developing CHF in their lifetime. It is the leading cause of hospitalizations in patients over 65 years of age, about 1 in 3 patients admitted to hospital will die...
Programme: H2020-EU.2.1.5.
Record Number: 206541
Last updated on: 2017-05-23
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-06-29